Asia Pacific Large And Small-scale Bioprocessing Market Size & Outlook

The large and small-scale bioprocessing market in Asia Pacific is expected to reach a projected revenue of US$ 966.5 million by 2030. A compound annual growth rate of 9.2% is expected of Asia Pacific large and small-scale bioprocessing market from 2024 to 2030.
Revenue, 2023 (US$M)
$522.3
Forecast, 2030 (US$M)
$966.5
CAGR, 2024 - 2030
9.2%
Report Coverage
Asia Pacific

Asia Pacific large and small-scale bioprocessing market, 2018-2030 (US$M)

Asia

Asia Pacific large and small-scale bioprocessing market highlights

  • The Asia Pacific large and small-scale bioprocessing market generated a revenue of USD 522.3 million in 2023.
  • The market is expected to grow at a CAGR of 9.2% from 2024 to 2030.
  • In terms of segment, proteases was the largest revenue generating type in 2023.
  • Proteases is the most lucrative type segment registering the fastest growth during the forecast period.


Asia Pacific data book summary

Market revenue in 2023USD 522.3 million
Market revenue in 2030USD 966.5 million
Growth rate9.2% (CAGR from 2023 to 2030)
Largest segmentProteases
Fastest growing segmentProteases
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationProteases
Key market players worldwideMerck KGaA, Thermo Fisher Scientific Inc, GE HealthCare Technologies Inc Common Stock, Corning Inc, Sartorius AG, Eppendorf, Getinge AB ADR, Lonza Group Ltd, PBS Biotech, Meissner, CellGenix, Boehringer Ingelheim, Samsung BioLogics, CMC Biologics, Binex, Rentschler Biopharma SE, Toyobo Co Ltd, Innovent Biologics Inc, Roche


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 24.0% of the global large and small-scale bioprocessing market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 966.5 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Large And Small-scale Bioprocessing Market Scope

Large and small-scale bioprocessing market segmentation & scope
Proteases
Polymerase & Transcriptase
Ribonuclease
Others
End Use
Pharma & Biotech
Hospital & Diagnostic Labs
Contract Research Organizations (CROs)
Academic Labs
Countries
Argentina
Brazil
Mexico
UK
Germany
France
Italy
Spain
Sweden
Denmark
Norway
U.S.
Canada
UAE
Saudi Arabia
South Africa
Kuwait
Thailand
South Korea
India
China
Japan
Australia

Large And Small-scale Bioprocessing Market Companies

Name Profile # Employees HQ Website

Asia Pacific large and small-scale bioprocessing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to large and small-scale bioprocessing market will help companies and investors design strategic landscapes.


Proteases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific large and small-scale bioprocessing market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Asia Pacific large and small-scale bioprocessing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific large and small-scale bioprocessing market databook

  • Our clientele includes a mix of large and small-scale bioprocessing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific large and small-scale bioprocessing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific large and small-scale bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific large and small-scale bioprocessing market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more